A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis
Accurate spinal tuberculosis (TB) diagnosis is of utmost importance for adequately treating and managing the disease. Given the need for additional diagnostic tools, this study aimed to investigate the utility of host serum miRNA biomarkers for diagnosing and distinguishing spinal tuberculosis (STB)...
Main Authors: | Qiang Liang, Weidong Jin, Zhigang Huang, Huquan Yin, Shengchun Liu, Liehua Liu, Xiangwei Song, Zili Wang, Jun Fei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1125946/full |
Similar Items
-
Clinical efficacy and safety of ultra-short-course chemotherapy in treatment of spinal tuberculosis after complete debridement: an observational study
by: Guangwei Sun, et al.
Published: (2021-02-01) -
Development of diagnostic algorithm using machine learning for distinguishing between active tuberculosis and latent tuberculosis infection
by: Ying Luo, et al.
Published: (2022-12-01) -
Biosignatures: The answer to Tuberculosis diagnosis in children?
by: Pierre Goussard, et al.
Published: (2020-10-01) -
A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children
by: Toyin Togun, et al.
Published: (2020-08-01) -
Specific microRNAs for Modulation of Autophagy in Spinal Cord Injury
by: Rhett Visintin, et al.
Published: (2022-02-01)